WallStreetZenWallStreetZen

NASDAQ: EYPT
Eyepoint Pharmaceuticals Inc Stock Ownership - Who owns Eyepoint Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Eyepoint Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jay S. DukerPresident and CEO2025-03-1920,000$6.16
$123.10kSell
Jay S. DukerPresident and CEO2025-02-092,055$6.50
$13.35kSell
Jay S. DukerPresident and CEO2025-01-066,108$8.68
$53.02kSell
George ElstonChief Financial Officer2025-01-064,808$8.68
$41.73kSell
George ElstonChief Financial Officer2025-01-055,267$8.26
$43.51kSell
Jay S. DukerPresident and CEO2025-01-0510,007$8.26
$82.66kSell
Goran AndoDirector2024-08-215,000$7.95
$39.75kBuy
Wendy F. DiciccoDirector2024-08-202,567$7.79
$20.00kBuy
Karen L. ZaderejDirector2024-08-1912,500$7.98
$99.75kBuy
Nancy LurkerDirector2024-08-163,173$7.88
$25.00kBuy

1 of 3

EYPT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EYPT insiders and whales buy or sell their stock.

EYPT Shareholders

What type of owners hold Eyepoint Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ew Healthcare Partners LP127.02%87,298,833$553.47MInsider
Pfizer Inc108.37%74,483,748$472.23MInsider
Ronald W. Eastman25.04%17,212,648$109.13MInsider
Cormorant Asset Management LP17.25%11,855,943$75.17MInsider
Cormorant Asset Management LP12.11%8,325,000$52.78MInstitution
Suvretta Capital Management LLC9.87%6,783,091$43.00MInstitution
Adage Capital Partners GP LLC8.37%5,750,000$36.46MInstitution
Blackrock Inc7.68%5,281,375$33.48MInstitution
Adage Capital Management LP7.50%5,156,299$32.69MInsider
Franklin Resources Inc6.02%4,137,567$26.23MInstitution

1 of 3

EYPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EYPT27.24%72.76%Net BuyingNet Selling
AUTL63.24%0.00%
PRTC0.14%0.00%
ERAS72.86%27.14%Net Buying
STOK47.97%52.03%Net SellingNet Buying
View Top Biotech Stocks

Eyepoint Pharmaceuticals Stock Ownership FAQ

Who owns Eyepoint Pharmaceuticals?

Eyepoint Pharmaceuticals (NASDAQ: EYPT) is owned by 107.90% institutional shareholders, 288.15% Eyepoint Pharmaceuticals insiders, and 0.00% retail investors. Ew Healthcare Partners LP is the largest individual Eyepoint Pharmaceuticals shareholder, owning 87.30M shares representing 127.02% of the company. Ew Healthcare Partners LP's Eyepoint Pharmaceuticals shares are currently valued at $544.74M.

If you're new to stock investing, here's how to buy Eyepoint Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.